RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22

Go back to RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.55 -0.02 (3.51%)
Previous Close $0.57    52 Week High $16.54 
Open $0.56    52 Week Low $8.10 
Day High $0.57    P/E N/A 
Day Low $0.55    EPS $0.00 
Volume 12,253